The Raf/MEK/ERK kinase cascade is pivotal in transmitting signals from membrane receptors to transcription factors that control gene expression culminating in the regulation of cell cycle progression. This cascade can prevent cell death through ERK2 and p90
Rsk activation and phosphorylation of apoptotic and cell cycle regulatory proteins. The PI3K/Akt kinase cascade also controls apoptosis and can phosphorylate many apoptotic and cell cycle regulatory proteins. These pathways are interwoven as Akt can phosphorylate Raf and result in its inactivation, and Raf can be required for the antiapoptotic effects of Akt. In this study, the effects of activated Raf (Raf-1, A-Raf and B-Raf) and PI3K/Akt proteins on abrogation of cytokine dependence in FL5.12 hematopoietic cells were examined. Activated Raf, PI3K or Akt expression, by themselves, did not readily relieve cytokine dependence. The presence of activated Raf and PI3K/Akt increased the isolation of factor-independent cells from 400-to 2500-fold depending upon the particular combination examined. The individual effects of activated Raf and Akt on proliferation, apoptosis and autocrine growth factor synthesis were further examined with hormoneinducible constructs (DRaf-1:AR and DAkt:ER*(Myr + ). Activation of either Raf or Akt hindered cell death; however, both proliferation and maximal synthesis of autocrine cytokines were dependent upon activation of both signaling pathways. The effects of small molecular weight inhibitors on DNA synthesis and cytokine gene expression were also examined. The PI3K inhibitor, LY294002, inhibited growth and cytokine gene expression. This effect could be synergistically increased by addition of the MEK inhibitor UO126. These cells will be useful in elucidating the interactions between Raf/MEK/ ERK and PI3K/Akt cascades in proliferation, apoptosis,
Introduction
Cytokine stimulation of hematopoietic cells leads to the rapid activation of phosphatidylinositol 3-kinase (PI3K) by creating a PI3K binding site on the interleukin-3 (IL-3) receptor (R) b c chain. PI3K consists of an 85 kDa regulatory subunit, which contains SH2 and SH3 domains and a 110 kDa catalytic subunit. The p85 subunit SH2 domain associates with the site on the b c chain Minshall et al., 1996; Craddock and Welham, 1997; McIlroy et al., 1997; Vanhaesebroeck et al., 1997; Duronio et al., 1998; Kubota et al., 1998; Blalock et al., 1999; McCubrey et al., 2000a McCubrey et al., , 2000b Scheid and Woodgett, 2001 ). The p85 subunit is then phosphorylated, which leads to activation of the p110 catalytic subunit. Activated PI3K phosphorylates the membrane lipid phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P 2 ] to result in phosphatidylinositol (3,4,5)-tris-phosphate [PtdIns(3,4,5)P 3 ]. The lipid products of PI3K serve to localize and activate additional downstream signal transduction molecules in the vicinity of the cell membrane. Phosphatidylinositoldependent kinase (PDK-1) is translocated to the cell membrane through its lipid binding pleckstrin homology (PH) Scheid and Woodgett, 2001; Wick et al., 2000; Williams et al., 2000) .
Activation of Akt occurs in two phases: targeting to the lipid-rich cell membrane by the N-terminal PH domain and phosphorylation on serine/threonine (S/T) residues (de Peso et al., 1997; Scheid and Scheid and Woodgett, 2001; Wick et al., 2000; Williams et al., 2000) . Phosphorylation of T308 in the catalytic domain and S473 in the carboxyl-terminal domain results in the activation of Akt. After activation by PtdIns(3,4,5)P 3 , PDK1 may phosphorylate T308, which alters the conformation of Akt. Akt is then phosphorylated by a putative second PDK. Activated Akt can phosphorylate many downstream targets, which result in prevention of apoptosis, including Bad, glycogen synthetase-3 kinase-b (Gsk-3b), forkhead transcription factor (Foxo-3) and in some cases, caspase-9 (in human cells).
The Ras/Raf/MEK/ERK signal transduction cascade is often induced after mitogen or growth factor ligation of receptor complexes (Blalock et al., 1999) . Ras is an apical member of multiple signal transduction pathways as it can activate both the PI3K/Akt and Raf/MEK/ ERK pathways. Certain Ras isoforms have different effects on PI3K and Raf activation. For example, HaRas preferentially activates PI3K, whereas Ki-Ras activates Raf (Yan et al., 1998) . The Raf family of S/T kinases consists of Raf-1, A-Raf and B-Raf. Raf-1 (a.k.a. c-Raf) was the first Raf gene isolated and is ubiquitously expressed (Storm and Rapp, 1993; Rapp et al., 1998; McCubrey et al., 1998) . A-Raf, however, is only expressed in urogenital organs including the kidney, testis, ovary, prostate and epididymis and in hematopoietic cells (McCubrey et al., 1998; Sutor et al., 1999) . B-Raf expression was first detected in neuronal cells, however, other studies have also shown that it is expressed in hematopoietic cells (Eychene et al., 1995; McCubrey et al., 1998; Blalock et al., 1999) . The rank order of the Raf family members to phosphorylate MEK1 is B-Raf>Raf-1bA-Raf Woods et al., 1997; McCubrey et al., 1998 McCubrey et al., , 2000a . Recently, it has been shown that B-Raf is important in the regulation of Raf-1 activity (Mizutani et al., 2001) . Interestingly, it has been proposed that A-Raf is the more important kinase in transmitting growth promoting signals in certain hematopoietic cells and A-Raf is the most efficient Raf family member to relieve the cytokine dependence of two other hematopoietic cell lines, FDC-P1 and TF-1 (McCubrey et al., 1998 Sutor et al., 1999; Hoyle et al., 2000 Hoyle et al., , 2000b Moye et al., 2000; Weinstein-Oppenheimer et al., 2000a .
Multiple events are involved in the activation of the Raf proteins. Ras induces the translocation of the Raf protein to the cellular membrane where it may be phosphorylated on tyrosine (Y) residues by activated Src family kinases and a variety of S/T kinases including p21-activated kinase (PAK), protein kinases A and C (PKA and PKC) and Akt (Carroll and May, 1994; Marais et al., 1995; Marshall, 1995; Khosravi-Far et al., 1996; Mischak et al., 1996; Chaudhary et al., 2000; Dhillon et al., 2002a Dhillon et al., , 2002b .
Dimerization is also a mechanism that regulates in the activation of the Raf proteins (Weber et al., 2001) . Although it was originally thought that the Raf proteins homodimerized, recently it was shown that Ras can induce the heterodimerization of different Raf proteins (Raf-1 and B-Raf) which may lead to additional biochemical specifities and activities (Weber et al., 2001) .
Downstream of the Raf proteins is MEK1, a dual S/T and Y kinase (Blalock et al., 1999) . MEK further transmits the signal to the extracellular regulated S/T kinases ERK1 and ERK2, which in turn phosphorylate the p90 ribosomal S6 kinase (p90 Rsk ) and other CREB kinases (Xing et al., 1996) . p90
Rsk is activated by ERK and PDK1, and it phosphorylates Bad and CREB. ERK and CREB kinases phosphorylate transcription factors including Elk and CREB which enter the nucleus to regulate gene transcription (Bonni et al., 1999; Shimamuri et al., 2000) . Thus, the Ras/Raf/MEK/ ERK signal transduction cascade can transduce signals originating from membrane receptors to DNA transcription factors.
It has been shown that there are other sites of interaction between the PI3K/Akt and Raf/MEK/ERK pathways (e.g., Raf, CREB and Bcl-2) (Datta et al., 1997; Bonni et al., 1999; Fang et al., 1999; Scheid et al., 1999; Tan et al., 1999; Zhou et al., 2000) . In some scenarios, Raf activity is necessary for the antiapoptotic effects of the PI3K/Akt pathway (Majewski et al., 1999) . Thus, these two signal transduction pathways are interlinked and further understanding of how they interact may lead to new therapies that are more efficacious in cancer treatment. The following studies were performed to test the hypothesis that expression of activated Raf/MEK/ERK and PI3K/Akt pathways could synergize and result in the abrogation of cytokine dependence of hematopoietic cells.
Results
Effects of individual PI3K, Akt, and Raf proteins on the cytokine dependence of FL5.12 cells
The murine FL5.12 hematopoietic cell line requires either IL-3 or GM-CSF to proliferate (McKearn et al., 1985; McCubrey et al., 1989; Blalock et al., 2001 ). This cell line was chosen to determine whether there are interactions between the Raf and PI3K/Akt pathways in abrogation of cytokine dependence because it is not transformed to factor independence by activated Raf alone (see below). The goal of the following experiments was to test the hypothesis that activated Raf and/or PI3K/Akt expression could synergize and abrogate the cytokine dependence of FL5.12 cells. Abrogation of cytokine dependence is an important event in leukemogenesis (Blalock et al., 1999) . A brief description of the different retroviruses used in this study and their individual effects on the cytokine dependence of FL5.12 cells is presented in (Table 1) . It should be noted that the activated Akt allowed the cells to persist and initially proliferate for 2-3 weeks in the absence of exogenous IL-3; however, stable cytokine-independent cell lines were not recovered after infection with this oncogene alone. As controls, the effects of kinase inactive (KI) DRaf-1[301]:ER and dominant negative (DN) Dp85a on the cytokine dependence of FL5.12 cells were determined. Infection of FL5.12 cells with retroviruses encoding these modified oncogenes did not result in the isolation of cytokine-independent cells. As an additional control, the effects of BCR-ABL on the cytokine dependence of FL5.12 cells were examined. In contrast to the results observed with activated Raf, PI3K and Akt, BCR-ABL readily abrogated the cytokine dependence of FL5.12 cells as approximately 10% of the BCR-ABL-infected cells were able to grow in the absence of exogenous cytokines (Table 1) .
Interactions between the Raf/MEK/ERK and PI3K/Akt pathways in promoting proliferation
The Raf/MEK/ERK and PI3K/Akt signal transduction cascades represent key pathways that regulate cellular proliferation, yet little is known concerning the ability of these pathways to interact in normal and malignant cell growth. The requirement of a functional PI3K pathway in Raf-mediated DNA synthesis was examined by two different approaches (Figure 1 Determined by limiting dilution analysis as presented in Figure 3 by comparing the frequency of isolation of cells that grew in the presence and absence of exogenous IL-3. Cells infected with conditional Raf and Akt genes were also plated in the presence of 4HT or testosterone, depending upon the particular construct they were infected with 
Effects of combinations of activated Raf and PI3K/Akt oncoproteins on the cytokine-dependence of FL5.12 cells
The effects of activated Raf and PI3K/Akt on the abrogation of cytokine-dependence were examined by performing limiting dilution analysis on pools of Raf and PI3K/Akt coinfected cells. As controls for these experiments, Raf-infected cells were also infected with WT PI3K (p85a, p85b, or p110), DNDp85a, and DAkt:ER*(Myr (Table 2) . However, cells growing in the absence of exogenous cytokines were recovered after infection with activated Raf and activated PI3K (p110) or Akt oncogenes. Their growth was conditional (see below) as they required the hormones which activated both Raf and Akt constructs (see below). Abrogation of cytokine dependence was also dependent upon a functional Raf and PI3K or Akt gene, as no cytokine-independent cells were recovered from cells infected with the KI DRaf-1[301]:ER encoding retrovirus that were subsequently infected with the activated PI3K/Akt genes ( Table 2) .
Higher frequencies of cells, which grew in response to 4HT in the absence of exogenous cytokines, were observed from DA-Raf:ER and PI3K/Akt-infected cells, whereas less cytokine-independent cells were recovered from DRaf:ER or DB-Raf:ER and PI3K/Akt-infected cells indicating that A-Raf was interacted with activated PI3K and Akt more efficiently than Raf-1 or B-Raf to relieve cytokine dependence (Table 2) . Thus, while the activated Raf and PI3K/Akt oncoproteins did not individually relieve the cytokine dependence of FL5.12 cells, coinfection with activated Raf and PI3K/Akt proteins did lead to abrogation of cytokine dependence in some cells. In contrast, coinfection with a WT Raf or PI3K gene or an empty retroviral vector did not result in the isolation of cytokine-independent cells. Ability of testosterone-regulated DRaf-1:AR and 4HT-regulated DAkt:ER*(Myr + ) to abrogate cytokine dependence of FL5.12 cells As homo-and heterodimerization can result in Raf activation (Farrar et al., 1996; Luo et al., 1996; Inouye et al., 2000; Weber et al., 2001) , the abilities of testosterone-regulated Raf and 4HT-regulated Akt genes to abrogate the cytokine dependence of FL5.12 Table 2 Effects of Raf and PI3K/Akt expression on the cytokine dependence of FL5.12 cells
Frequency of isolation of cytokine-independent cells a DRaf-1:ER o1 Â 10
Determined by limiting dilution analysis as presented in Figure 3 . The cells in the table were infected with the oncogene containing retroviruses, one from the vertical and one from the horizontal column Table 2 ). The addition of both 4HT and testosterone was required as cytokine-independent cells were not recovered from the cells plated in medium containing only 4HT or testosterone. The Myr + domain on the Akt construct was necessary for abrogation of cytokine dependence as no cytokine-independent cells were recovered from the DAkt:ER*(Myr Interactions between Raf/MEK/ERK and PI3K/Akt JG Shelton et al cells that remained IL3-dependent will be referred to from here on as IL3-dependent, whereas the Raf and PI3K/Akt cells that grew in response to Raf and PI3K/ Akt activation will be referred to as Raf & PI3K/Akt responsive.
Growth characteristics of Raf and Akt responsive cells
To determine how the activated Raf and Akt genes promoted proliferation, growth curve and DNA synthesis measurements were performed on the Raf-and Aktresponsive FL/DAkt:ER*(Myr + )+DRaf-1:AR cells (Figure 6 ). The highest levels of growth and DNA synthesis were observed when either IL-3 or both 4HT and testosterone were added. Activation of Raf, by the addition of testosterone, was able to promote a transient peak in DNA synthesis and growth at 3 days. Sustained proliferation and DNA synthesis required activation of both the Raf and Akt pathways. Conditional growth (e.g., requiring activation of Raf or Akt) was also observed in other Raf and PI3K/Akt responsive cells (e.g., FL/GFPDRaf-1:ER+PI3K(Act), FL/GFPDRaf-1:ER+Akt(Myr + )(Act), FL/DAkt:ER*(Myr + )+DRaf-1 and others).
Effects of activated Raf and Akt on the prevention of apoptosis in hematopoietic cells
Many studies have implicated the PI3K/Akt and Raf/ MEK/ERK pathways in the prevention of apoptosis (Vanhaesebroeck et al., 1997; Majewski et al., 1999; Blalock et al., 1999; McCubrey et al., 2000b McCubrey et al., , 2001a Scheid and Woodgett, 2001; von Gise et al., 2001) . To examine the effects of these pathways on the prevention of apoptosis, the annexin V/propidium iodide (PI) binding assay was employed (Figure 7) . Upon cytokine deprivation of the parental cytokine-dependent FL5.12 cell line for 2 days, only 9% of the cells registered as viable, and the other 91% were either apoptotic or dead (Panel a). When the cells were cultured in medium containing IL-3, 82% registered cells as viable (Panel b). In contrast, when these cells were cultured with 4HT, testosterone or the combination of 4HT and testosterone (Panels c-e) less than 5% of the cells registered as viable indicating neither 4HT or testosterone prevented apoptosis in the parental FL5.12 cells.
The effects of the individual DRaf:AR and DAkt:ER* oncoproteins on the prevention of apoptosis were also examined on Raf-and Akt-responsive cells (Panels f-j). In the absence of cytokine and hormones for 2 days, approximately 8% of the cells were viable (Panel f). In contrast, when the cells were cultured with IL-3 for 2 days, 75% of the cells were viable (Panel g). Culture of the cells in the presence of 4HT, which activated the DAkt:ER*(Myr + ), resulted in 41% of the cells registered as viable (Panel h). Treatment of the cells with testosterone led to 49% of the cells being viable (Panel i). Thus, neither Akt nor Raf activation by themselves resulted in the same level of viable cells as present in the IL-3-treated cells; however, activation of either Akt or Raf suppressed early events in apoptosis to a certain degree, however, these cells eventually underwent apoptosis. While activated Raf or Akt was able to significantly suppress apoptosis, neither of these pathways alone would suppress apoptosis to the same level as IL-3. When the cells were cultured in medium containing both 4HT and testosterone, 70% of the cells Interactions between Raf/MEK/ERK and PI3K/Akt JG Shelton et al registered as viable indicating that these two oncoproteins could each activate distinct pathways which could compliment each other to prevent apoptosis (Panel j).
Expression of autocrine cytokines in Raf-and Akt-responsive cells
To determine whether the Raf-and Akt-transduced cells secreted a growth factor that would support the growth of the parental as well as themselves, the presence and significance of autocrine growth factor activity was examined (Figure 8 ). Autocrine cytokines were detected when the supernatants prepared from the Raf-and Aktresponsive FL/DA-Raf:ER+DAkt:ER*(Myr (Figure 8, Panel d) . The a-GM-CSF Ab inhibited the DNA synthesis in the cells, whereas aIL-3, aIL-6 and no Ab treatment did not suppress DNA synthesis in these cells. GM-CSF will support the proliferation of the parental FL5.12 cells (Blalock et al., 2001) .
To determine whether activated Akt or Raf induced the synthesis of GM-CSF mRNA, FL/ta;Akt:ER(Myr + )+DRaf-1:AR cells were cultured in the indicated conditions for 2 days and then mRNAs and supernatants were harvested and analysed for GM-CSF and IL-3 cDNAs and growth factor activity, respectively ( Figure 9 ). cDNAs encoding IL-3 were not detected in these cells (Figure 9 , Panel a). However, they were observed in phorbol ester stimulated EL4 thymoma and WEHI-3B cells (data not presented). No GM-CSF cDNAs were observed in either untreated or IL-3-treated cells (Panel a). A faint GM-CSF cDNA band was observed when the cells were treated with 4HT. GM-CSF cDNAs were detected at higher levels when the cells were treated with 4HT and testosterone. Interactions between Raf/MEK/ERK and PI3K/Akt JG Shelton et al have as significant of an effect on DNA synthesis in these cells (5.7-and 3.5-fold, respectively). Thus, Raf and Akt responsive growth was most sensitive to the combined treatment with MEK and PI3K inhibitors.
Discussion
Akt and the related serum glucocorticoid-inducible kinase (SGK) may negatively regulate the Raf kinases, Raf-1 and B-Raf by phosphorylation of S259 and S364 of Raf-1 and B-Raf, respectively (Rommel et al., 1999; Zimmermann and Moelling, 1999; Guan et al., 2000; Zhang et al., 2001) . However, other investigators have observed that PKA can phosphorylate S259 on Raf-1 (Dhillon et al., 2002a, b) . A few studies have documented positive interactions between the PI3K/Akt and Raf/ MEK/ERK cascades (Majewski et al., 1999; McCubrey et al., 2001a, b; Gelfanov et al., 2001; von Gise et al., 2001) ; however, the ability of these pathways to interact and result in malignant transformation has not been well described. Previously we demonstrated that expression of activated Raf and MEK-1 oncoproteins will relieve the cytokine dependence of human TF-1 and murine FDC-P1 cells (McCubrey et al., 1998 2001a, b; Weinstein-Oppenheimer et al., 2000a, b; Blalock et al., 2000a Blalock et al., , b, 2001a Hoyle et al., 2000; Moye et al., 2000) . However, it should be pointed out that not all Raf-and MEK-infected TF-1 and FDC-P1 cells were factor independent after infection with activated Rafand MEK oncoproteins. In this study, we determined whether activated Raf could relieve the cytokine dependence of FL5.12 cells and unlike TF-1 and FDC-P1 cells, FL5.12 cells were resistant to transformation by aberrant Raf expression alone. The molecular basis for this difference in the ability of Raf to abrogate the cytokine dependence of TF-1 and FDC-P1 but not FL5.12 cells is not clear. However, we have since determined that FDC-P1 cells, which are more sensitive to transformation by activated oncogenes, lack certain tumor suppressor genes such as p15
Ink4b and do not express full-length p53 (Fumin Chang and JAM unpublished results) (McCubrey et al., 1991 (McCubrey et al., , 1993 Chang and McCubrey, 2001; Chang et al., 2002) .
FL5.12 cells represent a good cell system to study the effects of Raf on proliferation as they are not transformed solely by activated Raf oncogenes and they allow the investigation of the ability of other pathways to interact with Raf to result in growth in the absence of exogenous cytokines. In the present study, we sought to examine the involvement of the PI3K/Akt pathway on Raf-mediated proliferation and the prevention of apoptosis. Raf-induced DNA synthesis was dependent upon PI3K activity as it could be inhibited by DN Dp85a or the PI3K inhibitor LY294002 (Figure 1 ). The effects of activated Raf and PI3K/Akt on the proliferation and cytokine dependence of FL5.12 cells were further examined by introduction of conditional and constitutively active Raf and Akt constructs into the cells. By themselves, the conditionally activated Raf and Akt conditional proteins induced a low level of [ 3 H]thymidine incorporation that was dependent upon the dose of 4HT (Figure 2 ). This low level of DNA synthesis was increased upon introduction of either a Raf or Akt gene into the cells, indicating that activation of both pathways resulted in an increase in the ability of the cells to initiate DNA synthesis in the absence of exogenous cytokines (Figure 2) . While induced expression of either the Raf or the PI3K/Akt cascades by themselves did not relieve the cytokine dependence of FL5.12 cells, activation of both cascades resulted in the recovery of cells that would proliferate in the absence of exogenous cytokines ( Table 2 ). The cells which grew in response to Raf and PI3K/Akt were determined to express higher levels of DRaf:ER proteins and synthesize GM-CSF, and neutralization of this synthesis, by treatment of the cells with antibodies directed to GM-CSF, resulted in growth inhibition. Thus, Raf-and PI3K/Akt-responsive cells have an autocrine loop of proliferation. Cytokine-dependent cells infected by activated Raf and PI3K/Akt express lower levels of the Raf proteins and did not express GM-CSF mRNA transcripts (data not presented). For maximal effects of this autocrine loop, activation of both the Raf and PI3K/Akt pathways was necessary, although GM-CSF transcripts were detected when DRaf-1:AR was activated by testosterone treatment (Figure 9 ). While Raf activation by itself resulted in the detection of GM-CSF cDNAs, both pathways may synergize to result in enhanced levels of GM-CSF mRNA levels. The facts that: (1) GM-CSF was observed when only Raf was activated, (2) an aGM-CSF Ab did not completely eliminate growth and (3) the greatest inhibition of growth was observed when both the Raf/MEK/ERK and PI3K/Akt pathways were inhibited indicated that there are additional biochemical events other than GM-CSF expression that are required for optimal proliferation.
The GM-CSF promoter region contains CREB binding sites and phosphorylation and activation of the CREB transcription factor is regulated by both the Raf/MEK/ERK and PI3K/Akt pathways (Blalock et al., 1999; McCubrey et al., 2001c, d) . This transcription factor represents a potential molecular lynchpin that may account for the synergistic effects observed in these studies. The role of CREB and other transcription factors (such as Elk) in Raf and Akt responsive growth is currently being investigated.
All three Raf family members, A-Raf, B-Raf and Raf-1 could interact with activated PI3K/Akt family members to transform FL5.12 cells into cells that would grow in the absence of exogenous growth factors. A-Raf in combination with PI3K/Akt was more efficient in abrogating cytokine dependence than either Raf-1 or B-Raf in combination with PI3K/Akt. This result is in agreement with our previous observations which indicated that A-Raf was more efficient than either Raf-1 or B-Raf in relieving the cytokine dependence of FDC-P1 and TF-1 cells (McCubrey et al., 1998 Hoyle et al., 2000; Moye et al., 2000) . A-Raf is a weaker inducer of p21
Cip1 than either Raf-1 or B-Raf (Woods Chang et al., 2002) and A-Raf has been associated with proliferation (McCubrey et al., 1998 Sutor et al., 1999; Hoyle et al., 2000; Moye et al., 2000) . Activated Raf and PI3K/Akt proteins were necessary for the progression to cytokine independence. Higher levels of Raf proteins were detected in the cytokine independent than the cytokine-dependent cells as the level of green fluorescent protein (GFP) expression could be readily determined as some modified Raf proteins had the GFP moiety (data not presented). Factor-independent cells were not recovered from FL5.12 cells infected with either WT Raf-1, KI Raf-1, WT PI3K, DN PI3K genes indicating that overexpression of the WT genes did not readily lead to cytokine independence. Moreover, few factor-independent clones were recovered from cells infected with Raf and the DAkt:ER*(Myr Our studies indicate that activation of both the Raf and PI3K/Akt pathways was necessary for optimal proliferation and the prevention of apoptosis. Thus, it can be concluded that activation of just one pathway does not initiate a sufficient antiapoptotic response for the prevention of apoptosis in these cells. This indicates that suboptimal activation of various kinases, transcription factors and antiapoptotic proteins occurs in the absence of activation of both pathways. Moreover, consistent with this observation, cytokine gene expression was also detected at highest levels when both pathways were activated. While cytokine gene expression could be inhibited after treatment with MEK inhibitors, it was suppressed to a much higher degree after treatment with MEK and PI3K inhibitors. Hence in these cells, we have determined that these two pathways interact to regulate cellular proliferation and prevent apoptosis. ) +DRaf-1:AR were cultured in medium containing 500 nm 4HT+500 nm testosterone (Sigma).
Materials and methods

Cell lines and growth factors
In some cases, cells were treated with the MEK inhibitor UO126 (1 mm, Promega, Madison, WI, USA) or the PI3K inhibitor LY294002 (10 mm, Calbiochem, San Diego, CA, USA). These inhibitors were dissolved in dimethyl-sulfoxide (DMSO, Sigma).
Description of PI3K, Akt and Raf constructs and retroviral infection of cells
WT PI3K p85a, WT PI3Kb, DN Dp85, WT p110 PI3K and constitutively active (Act) PI3K proteins were used in these studies. The constitutively active p110 PI3K contains a lysine to glutamic acid substitution (K227E) in the Ras binding domain. These PI3K constructs were generously provided by Dr Julian Downward (ICRF, London, England, UK) . The PH domain deleted (DPH) Akt proteins either had or lacked a v-Src-encoded myristolation sequence (Myr + ) that would target the Akt protein to the cytoplasmic membrane (Kohn et al., 1996) . Some Akt kinase constructs were conditionally active as the modified kinase domains were fused to the mutated hormone binding domain of the estrogen receptor (hbER*) which rendered their catalytic activity dependent upon the presence of the estrogen-receptor antagonist 4HT (Mizra et al., 2000) . ] lacking the ER domain was also used in these studies (Kohn et al., 1996) . This construct was in a retroviral vector encoding resistance to neomycin (neo r ) and stably infected cells were isolated in the presence of 2 mg/ml G418 (Invitrogen).
Conditionally active Raf constructs encode N-terminal deleted Raf proteins fused to the hbER (Samuels et al., 1993; Pritchard et al., 1995; Bosch et al., 1997; Woods et al., 1997) . The N-terminal deletion renders the Raf proteins active, however, they are conditionally active as they are fused to the hbER. The effects of three different conditionally active DRaf:ER proteins were examined in these studies, DA-Raf:ER, DB-Raf:ER and DRaf-1:ER (Pritchard et al., 1995; Bosch et al., 1997) . A conditionally active Raf-1 gene also used in these studies has the GFP moiety attached (GFPDRaf-1:ER, Woods et al., 1997) . The DRaf-1[301]:ER construct encodes a kinaseinactive Raf protein that has a lysine (K) to tryptophan (W) substitution in the kinase domain McMahon, 2001) . The DA-Raf:ER, DB-Raf:ER, DRaf-1:ER, GFPDRaf-1:ER, DRaf-1[301]:ER and DRaf-1:AR are contained in the pBP3puro retroviral vector that encodes resistance to puromycin (Morgenstern and Land, 1990; McMahon, 2001) . Puro r cells were isolated in medium containing 1 mg/ml puromycin (Sigma). All ER chimeric proteins respond to 4HT, so 4HT was used throughout these experiments. The DRaf-1:AR encodes a N-terminal deleted Raf-1 protein fused to the hb domain of the androgen receptor (AR) and responds to testosterone (Lloyd et al., 1997) . Finally, the effects of WT Raf-1, CA DRaf-1 and an empty retroviral vector (pLNL6) (Kaleko et al., 1990; Samuels et al., 1993) on the cytokine dependence were also examined. These latter constructs were contained in vectors which encoded neo r .
Plasmid DNAs containing recombinant retroviruses were transfected into the retroviral packaging cell lines c2 or PA317 with lipofectin (Invitrogen) and retroviruses were passed sequentially from one cell line to the other to amplify their titers as described (McCubrey et al., 1998) . Hematopoietic cells were infected with viral stocks as described (McCubrey et al., 1998) .
Proliferation and apoptosis assays
Cells were washed three times with phosphate-buffered saline (PBS) before being set up for proliferation assays, FACS analysis, annexin V/PI binding or cytokine gene expression. Growth curves were performed in 5 ml of medium with the indicated supplements in T25 tissue culture flasks (Corning, Corning, NY, USA). [ 3 H]-incorporation assays were performed in a 96-well flat bottom plates (Corning) with initially 10 4 cells/well that were incubated for 1 day in the presence of the indicated supplements. The supplements could include different dilutions of 4HT, IL-3 or various concentrations of filter-sterilized cell supernatants to determine whether or not the cells were producing autocrine growth factors. In some cases, the supernatants were incubated with different concentrations of antibodies (Abs) to IL-3, GM-CSF or IL-6 (R&D Systems, Minneapolis, MN, USA) for 1 h before the indicator cells were added to determine which cytokine the cells were expressing. Also, in some cases the cytokine-producing cells were incubated for 24 h with the aIL-3 and aGM-CSF Abs to determine the effects of these antibodies on cell growth. During the last 6 h of incubation, cellular proliferation was assayed by adding [ 3 H]thymidine (6.7 Ci/mmol, NEN, Boston, MA, USA) as described (McCubrey et al., 1998) .
Analysis of GFPDRaf-1:ER protein expression
The expression of the GFPDRaf-1:ER protein was monitored by flow cytometric analysis. The cells were washed once with PBS and then analysed for fluorescence intensity on the Becton Dickinson FacStar analyzer. Uninfected parental cells were used as negative controls since they lacked the GFP moiety.
Polymerase chain reaction amplification of cytokine mRNA transcripts
Total cytoplasmic RNAs was prepared as described (McCubrey et al., 1998) and 1 mg was included in a 20 ml cDNA synthesis reaction containing: reverse transcriptase buffer, 1 mm of each dNTP, 20 mg/ml oligo-dT and 20 U Mo-MuLV reverse transcriptase. After incubation at 421C for 40 min, the reaction was terminated by addition of H 2 O. For PCR amplification, 5 ml of cDNA were included in a 50 ml reaction mixture containing PCR buffer, dNTPs, 1-2 U Taq polymerase and 1 mm of each oligonucleotide primer. The primers for murine IL-3 were: 5 0 AATCAGTGGCCGGGATACCC3 0 and 5 0 CGAAATCATCCAGATCTCG3 0 defining a 200 bp cDNA fragment that could readily be distinguished from a genomic IL-3 DNA fragment by size (>1 kB). The primers for murine GM-CSF were: 5 0 CCTGAGGAGGATGTGGCTGC3 0 and 5 0 CTGTCCAAGCTGAGTCAGCG3 0 defining a 601 bp fragment. The primers for murine b 2 -microglobulin were 5 0 TTCTCTCACTGACCGGCCTG3 0 and 5 0 CAGTAGACGG AGACGG TCTTGGGCTC3 0 defining a 308 bp fragment. A total of 40 cycles of PCR were performed to detect cytokine cDNAs. The PCR products were electrophoresed on 1% agarose gels and visualized after ethidium bromide staining of the gel.
Annexin V apoptosis assays
Approximately 1 Â 10 7 exponentially growing cells were collected by centrifugation. Cells were then treated in the indicated conditions for 48 h. The cells were transferred to 12 Â 75 mm 2 tubes and centrifuged at 800 g for 5 min at 41C. The supernatants were removed by aspiration, and the cell pellets were resuspended in 1 ml PBS. The cells were then centrifuged as before, and the supernatants were again aspirated. Following a second wash in PBS, the cells were stained with 100 ml of annexin V [Roche Diagnostics; 1 mg/ml in annexin V binding buffer (50 mm HEPES, pH 7.5, 125 mm NaCl, 2.5 mm CaCl 2 )]. The cells were incubated with annexin V for 30 min at RT in the dark. After incubation the cells were centrifuged as before, and the annexin V solution was removed by aspiration. The cells were washed once as before in 1 ml of PBS. The cells were resuspended in 100 ml of PI solution (Roche Diagnostics; 10 mg/ml in annexin V binding buffer) and incubated in the dark for 30 min at RT. Annexin V binding buffer (0.7 ml) was added directly to the samples prior to analysing on a Becton-Dickinson FACs analyser. Controls, which were unstained, stained with Annexin V only, or stained with PI only, were used to calibrate the FacStar analyzer for each experiment.
